Usona Institute

Conducts and supports pre-clinical and clinical research to further the understanding of the therapeutic effects of psilocybin, 5-meo-dmt, and other consciousness-expanding medicines. University of Wisconsin hospitals and clinics (uw) serves as a clinical research center associated with the university of wisconsin-madison. There are several Usona collaborations with the uw that include researchers and staff under appointment with the hospital. Usona has contracted safety and efficacy clinical studies with the uw for our drug development programs, offers internships, funds uw scholarships, and is building a future training program for clinical facilitators in partnership with the uw. Completed phase 2 clinical trial for psilocybin and are nearing completion of phase 1 for 5-meo-dmt.